Cysteine-containing cellular proteins

Cysteine-containing cellular proteins represent a vast and diverse group of molecules rather than a single therapeutic target. Cysteine is a unique amino acid characterized by a nucleophilic thiol side chain that plays critical roles in protein structure through disulfide bond formation, metal binding, and catalytic activity in various enzymes (e.g., cysteine proteases). In modern pharmacology, this 'cysteine proteome' is frequently exploited for the development of covalent inhibitors, where drugs are designed to form a permanent bond with a specific cysteine residue in a target protein like EGFR or BTK to achieve high potency and prolonged duration of action. However, because thousands of proteins contain accessible cysteines, achieving selectivity is a major challenge; non-specific interactions can lead to toxicity, glutathione depletion, or the formation of haptens that trigger immune responses. Consequently, while individual cysteine-containing proteins are valid targets, the collective term refers to a broad biological category involved in everything from redox signaling to structural integrity.

Other names

Cysteine proteomeThiol-containing proteinsSulfhydryl-containing proteins

Drugs typically interact with these proteins via covalent modification of the nucleophilic sulfur atom in the cysteine side chain (thiol group), often through Michael addition or SN2 substitution, leading to irreversible inhibition or functional modulation.